21.2 percent of US adults had diagnosed arthritis from 2019 to 2021

by Elana GotkineAn estimated 21.2 percent of U.S. adults had diagnosed arthritis from 2019 to 2021, with most cases among adults aged 45 years and older, according to research published in the Oct. 13

Updated on: February 18,2024 0

21.2 percent of US adults had diagnosed arthritis from 2019 to 2021

by Elana GotkineAn estimated 21.2 percent of U.S. adults had diagnosed arthritis from 2019 to 2021, with most cases among adults aged 45 years and older, according to research published in the Oct. 13

Updated on:February 18,2024 0

Psoriasis not caused by spontaneous mutations in skin cells, finds study

by Wellcome Trust Sanger InstituteCredit: Estzer Miller on PixabayPsoriasis—a chronic skin condition—is not caused or spread by spontaneous genetic mutations in the skin, new research suggests.Th

Updated on: January 28,2024 9

Psoriasis not caused by spontaneous mutations in skin cells, finds study

by Wellcome Trust Sanger InstituteCredit: Estzer Miller on PixabayPsoriasis—a chronic skin condition—is not caused or spread by spontaneous genetic mutations in the skin, new research suggests.Th

Updated on:January 28,2024 9

Biological agent trials for psoriasis rarely include patient images

by Elana GotkineFew randomized controlled trials involving biological agents for psoriasis treatment include patient images, according to a review published online on Nov. 15 in theJournal of De

Updated on: January 28,2024 10

Biological agent trials for psoriasis rarely include patient images

by Elana GotkineFew randomized controlled trials involving biological agents for psoriasis treatment include patient images, according to a review published online on Nov. 15 in theJournal of De

Updated on:January 28,2024 10

SRC-3 is a novel regulator of human immune T regulatory cells

by Baylor College of MedicineSuzanne Judd, Ph.D., an epidemiologist at UAB, explains what will lead to herd immunity and why it is important to remain vigilant in reducing the spread of COVID-19.

Updated on: April 22,2024 18

SRC-3 is a novel regulator of human immune T regulatory cells

by Baylor College of MedicineSuzanne Judd, Ph.D., an epidemiologist at UAB, explains what will lead to herd immunity and why it is important to remain vigilant in reducing the spread of COVID-19.

Updated on:April 22,2024 18

Having hypermobile joints may increase the risk for depression and anxiety in adolescents

by University of SussexPrevalence of generalized joint hypermobility. (A) Shows the difference in prevalence of GJH in participants who meet diagnostic criteria for ICD-10 depression (blue bar) a

Updated on: May 13,2024 4

Having hypermobile joints may increase the risk for depression and anxiety in adolescents

by University of SussexPrevalence of generalized joint hypermobility. (A) Shows the difference in prevalence of GJH in participants who meet diagnostic criteria for ICD-10 depression (blue bar) a

Updated on:May 13,2024 4

Arthritis & the COVID vaccine: What you need to know

(HealthDay)—Some arthritis drugs may reduce the effectiveness of COVID vaccines, according to the Arthritis Foundation, which also offers advice on booster shots.Research is limited, but evidence sugg

Updated on: May 13,2024 5

Arthritis & the COVID vaccine: What you need to know

(HealthDay)—Some arthritis drugs may reduce the effectiveness of COVID vaccines, according to the Arthritis Foundation, which also offers advice on booster shots.Research is limited, but evidence sugg

Updated on:May 13,2024 5

How long does immunity last after COVID vaccination, and do we need booster shots?

by Vasso Apostolopoulos, Jack Feehan,The ConversationCredit: Unsplash/CC0 Public DomainAn important factor in achievingherd immunityagainst SARS-CoV-2 (the virus that causes COVID-19

Updated on: April 13,2024 11

How long does immunity last after COVID vaccination, and do we need booster shots?

by Vasso Apostolopoulos, Jack Feehan,The ConversationCredit: Unsplash/CC0 Public DomainAn important factor in achievingherd immunityagainst SARS-CoV-2 (the virus that causes COVID-19

Updated on:April 13,2024 11

COVID-19 immunity may last six months or more

by Meghan Rosen,Howard Hughes Medical InstituteScientists found traces of SARS-CoV-2 (green) in cells lining people’s intestines three months after infection. Antibodies may evolve in response t

Updated on: April 10,2024 14

COVID-19 immunity may last six months or more

by Meghan Rosen,Howard Hughes Medical InstituteScientists found traces of SARS-CoV-2 (green) in cells lining people’s intestines three months after infection. Antibodies may evolve in response t

Updated on:April 10,2024 14

Research explores environmental pollutant BPA and asthma susceptibility in mice

by PNAS NexusTransmission electron microscopy images demonstrating the effects of BPA on E. coli LPS. Credit: Wang et al.The "hygiene hypothesis" posits that allergic asthma can be triggered

Updated on: January 28,2024 18

Research explores environmental pollutant BPA and asthma susceptibility in mice

by PNAS NexusTransmission electron microscopy images demonstrating the effects of BPA on E. coli LPS. Credit: Wang et al.The "hygiene hypothesis" posits that allergic asthma can be triggered

Updated on:January 28,2024 18

Could a nasal spray replace an EpiPen? Here's what an allergist says

by Tayler Shaw,CU Anschutz Medical CampusCredit: Unsplash/CC0 Public DomainFor the millions of Americans who have a food allergy, doctors recommend they always carry an epinephrine auto-injector

Updated on: September 11,2024 0

Could a nasal spray replace an EpiPen? Here's what an allergist says

by Tayler Shaw,CU Anschutz Medical CampusCredit: Unsplash/CC0 Public DomainFor the millions of Americans who have a food allergy, doctors recommend they always carry an epinephrine auto-injector

Updated on:September 11,2024 0

VOYAGE phase 3: Dupilumab significantly reduced asthma exacerbations in children age 6-11

byAmerican Thoracic SocietyCredit: CC0 Public DomainResults from the VOYAGE study of dupilumab (Dupixent) showed that the monoclonal antibody significantly reduced exacerbations in children ages

Updated on: March 02,2024 13

VOYAGE phase 3: Dupilumab significantly reduced asthma exacerbations in children age 6-11

byAmerican Thoracic SocietyCredit: CC0 Public DomainResults from the VOYAGE study of dupilumab (Dupixent) showed that the monoclonal antibody significantly reduced exacerbations in children ages

Updated on:March 02,2024 13

New findings on tuberculosis could change how we treat inflammatory disorders

by Katherine Fenz,Rockefeller UniversityCredit: Unsplash/CC0 Public DomainTuberculosis (TB) is a confounding scourge. It's the leading cause of death from infectious disease in the world, an

Updated on: September 03,2024 0

New findings on tuberculosis could change how we treat inflammatory disorders

by Katherine Fenz,Rockefeller UniversityCredit: Unsplash/CC0 Public DomainTuberculosis (TB) is a confounding scourge. It's the leading cause of death from infectious disease in the world, an

Updated on:September 03,2024 0